These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15799323)

  • 1. [Involvement of osteoclasts in cartilage and bone destruction in rheumatoid arthritis].
    Hikita A; Tanaka S
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():84-6. PubMed ID: 15799323
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of osteoclasts in bone destruction in rheumatoid arthritis].
    Suzuki Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2001 Jun; 24(3):87-97. PubMed ID: 16578961
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immune and skeletal systems].
    Takayanagi H
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():87-95. PubMed ID: 15799324
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molecular mechanisms of bone destruction in rheumatoid arthritis].
    Nanki T
    Clin Calcium; 2007 Apr; 17(4):510-6. PubMed ID: 17404479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Osteoclastic bone resorption in joint destruction of rheumatoid arthritis].
    Kawaguchi H
    Ryumachi; 2000 Feb; 40(1):32-8. PubMed ID: 10783664
    [No Abstract]   [Full Text] [Related]  

  • 7. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
    Takayanagi H; Iizuka H; Juji T; Nakagawa T; Yamamoto A; Miyazaki T; Koshihara Y; Oda H; Nakamura K; Tanaka S
    Arthritis Rheum; 2000 Feb; 43(2):259-69. PubMed ID: 10693864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of the bone destruction in rheumatoid arthritis].
    Nakamura M; Tanaka S
    Nihon Rinsho; 2005 Sep; 63(9):1571-3. PubMed ID: 16164213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.
    Urushibara M; Takayanagi H; Koga T; Kim S; Isobe M; Morishita Y; Nakagawa T; Löeffler M; Kodama T; Kurosawa H; Taniguchi T
    Arthritis Rheum; 2004 Mar; 50(3):794-804. PubMed ID: 15022321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM; Nishioka K; Yudoh K
    Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone and cartilage destruction in rheumatoid arthritis].
    Komatsu N; Takayanagi H
    Clin Calcium; 2012 Feb; 22(2):179-85. PubMed ID: 22298070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKL.
    Hui W; Cawston TE; Richards CD; Rowan AD
    Arthritis Res Ther; 2005; 7(1):R57-64. PubMed ID: 15642143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synovial fluid macrophages are capable of osteoclast formation and resorption.
    Adamopoulos IE; Sabokbar A; Wordsworth BP; Carr A; Ferguson DJ; Athanasou NA
    J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.
    Kong YY; Feige U; Sarosi I; Bolon B; Tafuri A; Morony S; Capparelli C; Li J; Elliott R; McCabe S; Wong T; Campagnuolo G; Moran E; Bogoch ER; Van G; Nguyen LT; Ohashi PS; Lacey DL; Fish E; Boyle WJ; Penninger JM
    Nature; 1999 Nov; 402(6759):304-9. PubMed ID: 10580503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo.
    Jimi E; Aoki K; Saito H; D'Acquisto F; May MJ; Nakamura I; Sudo T; Kojima T; Okamoto F; Fukushima H; Okabe K; Ohya K; Ghosh S
    Nat Med; 2004 Jun; 10(6):617-24. PubMed ID: 15156202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha promotes the expression of osteoprotegerin in rheumatoid synovial fibroblasts.
    Kubota A; Hasegawa K; Suguro T; Koshihara Y
    J Rheumatol; 2004 Mar; 31(3):426-35. PubMed ID: 14994384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Osteopontin in rheumatoid arthritis].
    Saeki Y
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():627-31. PubMed ID: 16279713
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Merger of bone biology and immunology].
    Suda T; Shima N; Higashio K
    Tanpakushitsu Kakusan Koso; 2002 Oct; 47(13):1837-43. PubMed ID: 12385106
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bone disease related to rheumatoid arthritis].
    Tanaka S
    Nihon Rinsho; 2006 Sep; 64(9):1712-7. PubMed ID: 16972685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.